Literature DB >> 34021179

Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors.

Kayo Togawa1,2, Huiyan Ma3, Ashley Wilder Smith4, Marian L Neuhouser5, Stephanie M George6,7, Kathy B Baumgartner8, Anne McTiernan5, Richard Baumgartner8, Rachel M Ballard6, Leslie Bernstein3.   

Abstract

We examined cross-sectional associations between arm lymphedema symptoms and health-related quality of life (HRQoL) in the Health, Eating, Activity and Lifestyle (HEAL) Study. 499 women diagnosed with localized or regional breast cancer at ages 35-64 years completed a survey, on average 40 months after diagnosis, querying presence of lymphedema, nine lymphedema-related symptoms, e.g., tension, burning pain, mobility loss, and warmth/redness, and HRQoL. Analysis of covariance models were used to assess HRQoL scores in relation to presence of lymphedema and lymphedema-related symptoms. Lymphedema was self-reported by 137 women, of whom 98 were experiencing lymphedema at the time of the assessment. The most common symptoms were heaviness (52%), numbness (47%), and tightness (45%). Perceived physical health was worse for women reporting past or current lymphedema than those reporting no lymphedema (P-value < 0.0001). No difference was observed for perceived mental health (P-value = 0.31). Perceived physical health, stress, and lymphedema-specific HRQoL scores worsened as number of symptoms increased (P-values ≤ 0.01). Women reporting tension in the arm had lower physical health (P-value = 0.01), and those experiencing burning pain, tension, heaviness, or warmth/redness in the arm had lower lymphedema-specific HRQoL (P-values < 0.05). Treatment targeting specific lymphedema-related symptoms in addition to size/volume reduction may improve some aspects of HRQoL among affected women.

Entities:  

Year:  2021        PMID: 34021179     DOI: 10.1038/s41598-021-89055-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  11 in total

Review 1.  Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011.

Authors:  Mei R Fu; Sheila H Ridner; Sophia H Hu; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  Psychooncology       Date:  2012-10-09       Impact factor: 3.894

2.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

3.  Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors.

Authors:  Deborah J Bowen; Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Leslie Bernstein; Kathy Meeske; Kathy B Baumgartner; Josala Fetherolf; Bryce B Reeve; Ashley Wilder Smith; Patricia A Ganz; Anne McTiernan; Rachel Ballard Barbash
Journal:  Breast Cancer Res Treat       Date:  2007-01-27       Impact factor: 4.872

4.  Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors.

Authors:  J M Hormes; C Bryan; L A Lytle; C R Gross; R L Ahmed; A B Troxel; K H Schmitz
Journal:  Lymphology       Date:  2010-03       Impact factor: 1.286

5.  Breast cancer-related lymphedema and sexual experiences: a mixed-method comparison study.

Authors:  M Elise Radina; Mei R Fu; Lori Horstman; Yang Kang
Journal:  Psychooncology       Date:  2015-03-16       Impact factor: 3.894

6.  Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: a prospective cohort study.

Authors:  Eun Joo Yang; Sung-Won Kim; Chan-Yeong Heo; Jae-Young Lim
Journal:  Support Care Cancer       Date:  2010-04-25       Impact factor: 3.603

Review 7.  Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes.

Authors:  Andrea L Pusic; Yeliz Cemal; Claudia Albornoz; Anne Klassen; Stefan Cano; Isabel Sulimanoff; Marisol Hernandez; Marga Massey; Peter Cordeiro; Monica Morrow; Babak Mehrara
Journal:  J Cancer Surviv       Date:  2012-12-05       Impact factor: 4.442

8.  Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study.

Authors:  L Aerts; M R Christiaens; P Enzlin; P Neven; F Amant
Journal:  Breast       Date:  2014-07-28       Impact factor: 4.380

9.  Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.

Authors:  Linda C Harlan; Carrie N Klabunde; Anita H Ambs; Todd Gibson; Leslie Bernstein; Anne McTiernan; Kathleen Meeske; Kathy B Baumgartner; Rachel Ballard-Barbash
Journal:  J Cancer Surviv       Date:  2009-05-13       Impact factor: 4.442

10.  Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study.

Authors:  Rehana L Ahmed; Anna Prizment; DeAnn Lazovich; Kathryn H Schmitz; Aaron R Folsom
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

View more
  2 in total

1.  Effect of Supervised Resistance Training on Arm Volume, Quality of Life and Physical Perfomance Among Women at High Risk for Breast Cancer-Related Lymphedema: A Study Protocol for a Randomized Controlled Trial (STRONG-B).

Authors:  Karol Ramírez-Parada; Maria Lopez-Garzon; Cesar Sanchez-Rojel; Militza Petric-Guajardo; Margarita Alfaro-Barra; Rodrigo Fernández-Verdejo; Alvaro Reyes-Ponce; Gina Merino-Pereira; Irene Cantarero-Villanueva
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

2.  Impact of Activity-Oriented Propioceptive Antiedema Therapy on the Health-Related Quality of Life of Women with Upper-Limb Lymphedema Secondary to Breast Cancer-A Randomized Clinical Trial.

Authors:  María Nieves Muñoz-Alcaraz; Luis A Pérula-de Torres; Antonio José Jiménez-Vílchez; Paula Rodríguez-Fernández; María Victoria Olmo-Carmona; María Teresa Muñoz-García; Presentación Jorge-Gutiérrez; Jesús Serrano-Merino; Esperanza Romero-Rodríguez; Lorena Rodríguez-Elena; Raquel Refusta-Ainaga; María Pilar Lahoz-Sánchez; Belén Miró-Palacios; Mayra Medrano-Cid; Rosa Magallón-Botaya; Mirian Santamaría-Peláez; Luis A Mínguez-Mínguez; Jerónimo J González-Bernal
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.